The unfolded protein response and apoptotic regulation in the human placenta due to maternal cigarette smoking and pre-eclampsia.


Journal

Reproductive toxicology (Elmsford, N.Y.)
ISSN: 1873-1708
Titre abrégé: Reprod Toxicol
Pays: United States
ID NLM: 8803591

Informations de publication

Date de publication:
10 2021
Historique:
received: 03 07 2021
revised: 31 08 2021
accepted: 02 09 2021
pubmed: 8 9 2021
medline: 4 3 2022
entrez: 7 9 2021
Statut: ppublish

Résumé

Maternal cigarette smoking (CS) and pre-eclampsia (PE) alter placental function and expression of important proteins which maintain homeostasis. Two interlinked pathways of interest are the unfolded protein response (UPR) and apoptosis. The UPR is upregulated in the PE placenta, but no data is available on the effects of CS and how it correlates with apoptotic expression. Samples of human placental tissue from normotensive non-smokers (n = 8), women with PE (n = 8), and CS (n = 8) were analysed using immunohistochemistry for 3 UPR markers (phosphorylated PKR-like endoplasmic reticulum (ER) kinase (pPERK), inositol-requiring enzyme 1 (IRE1), activating transcription factor 6 (ATF6)), and an antibody microarray for 19 apoptotic and stress regulating markers. For the PE group compared to the normotensive group, staining for pPERK was increased in decidual tissue and villi, and for IRE1, the overall percentage of stained villi per field of view was increased. There were no differences in UPR expression comparing CS to controls. Of the apoptotic markers, only IκBα (Ser32/36), which is part of an inhibitory pathway, showed a significant decrease in the PE and CS groups compared to controls. These findings suggest UPR regulation is more evident in PE with a general increase in ER stress due to decreased inhibition of apoptosis as compared to CS for which UPR was not altered.

Identifiants

pubmed: 34492309
pii: S0890-6238(21)00138-6
doi: 10.1016/j.reprotox.2021.09.001
pii:
doi:

Substances chimiques

ATF6 protein, human 0
Activating Transcription Factor 6 0
NF-KappaB Inhibitor alpha 139874-52-5
ERN1 protein, human EC 2.7.11.1
PERK kinase EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1
eIF-2 Kinase EC 2.7.11.1
Endoribonucleases EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-127

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

S Thomson (S)

Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia.

K A Waters (KA)

Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia.

A Hennessy (A)

School of Medicine, Western Sydney University, NSW, 2751, Australia; Heart Research Institute, The University of Sydney, NSW, 2006, Australia.

R Machaalani (R)

Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia. Electronic address: rita.machaalani@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH